Ethical Challenges in Modern Cardiovascular Medicine
In the past two decades, cardiology has experienced what many consider to be a revolution in the field. Advances in prevention, diagnosis, and treatment have created decision-making challenges not only for physicians and their patients but for the drug and device industries and society. October’s authors look closely at the ethical concerns raised by these new clinical alternatives, including the temptation to practice defensive medicine, use of statins in pediatric patients, government intervention in diet and lifestyle choices, pharmaceutical marketing practices, and disparities in access to care among cardiology patients.
Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets.
The phrase “I take Lipitor instead of a generic” was embedded in the public consciousness through an advertising campaign that featured Robert Jarvik, credited with the invention of the artificial heart.